Experiences with

Prialt

New, obscure, impressive, and probably not a cure: Found this on Twitter and went to the Chinese site and Google Translated it: "The day after the operation, my mother called out my name" Alzheimer's disease can also be treated surgically https://news.csu.edu.cn/info/1061/160033.htm Source

CAN-2409 is an immunotherapy drug currently in a Phase 3 clinical trial (PrTK03, NCT01436968) for individuals with intermediate-high risk localized prostate cancer. The trial, which is expected to conclude in December 2024, is evaluating the effectiveness of CAN-2409 in combination with radiation

The AMPLITUDE clinical trial (NCT04497844) is evaluating the effectiveness of Akeega, a combination of the PARP inhibitor niraparib and abiraterone acetate, along with prednisone, for treating metastatic castration-sensitive prostate cancer (mCSPC). This combination therapy is being compared to the

NOTE. This is the first time I have seen this this happening. I have found this new article, and…before I found this article, I have found a phase 3 clinical trial that is already applying these findings! Maybe a positive sign? Or an old article rebranded? Anyway look also for my other post about the

I am a bit slow, I am in Poland for work so I have to carve in the time to post. Mevrometostat (PF-06821497) is an experimental drug being investigated in a Phase III trial (NCT06551324) called MEVPRO-1. This trial is for men with metastatic castration-resistant prostate cancer (mCRPC) who have received

[u][i]Golexanolone[/i][/u] [i]A relatively new drug that is in clinical trial mostly being tested to help relieve cognitive and motor functions. It is hopefully to be used for Parkinson patients as well as those with hepatic encephalopathy in PBC. it was being tested in the laboratories

Let's keep hoping... A Seattle-based biotech firm, has received a $2.4 million grant to develop CTT2274, a new drug for metastatic prostate cancer. CTT2274 is a small molecule drug conjugate that targets PSMA. This targeted approach delivers a toxic payload, MMAE, directly to tumor cells, potentially

Anyone seen this? This is what JSBMD is talking about https://pmc.ncbi.nlm.nih.gov/articles/PMC11083272/#sec6-ijms-25-04643 Conclusions TH inhibitors down-regulate DA levels and protect DA neurons, while DA receptor agonists function to activate post-synaptic DA receptors to alleviate PD symptoms

Background: Participated in two clinical trials earlier this year however they were unsuccessful and I was removed from them after 1 o2 cycles Reason for Hospitalization: Malignant neoplasm of prostate [C61]. Care, Treatment, and Services Provided: Kevin Klott is a 59 y.o. male from Gladwin, Michigan

Hello, I am very grateful for this forum. By reading the many posts I have gained much better insight into the disease. I was diagnosed with PV 2 years ago. I am 52 years old and have no history of thrombosis. As a result I belong to the low risk group and I only started with aspirin and phlebotomy.

The Director Of Clinical Trials is pretty excited about this trial!

I am overwhelmed by some many replies from you brave men who are suffering from this cruel disease and from the wife’s and family members who are supporting their men and from the Wives like me that have lost their Husband’s /Partner and understand how I’m feeling right now; so lost. This is a poem

The new Levodopa pump has been approved by the FDA. Expected to be available through Medicare by summer 2025. Here is the link and followed by a Google Gemini created summary. https://news.abbvie.com/2024-10-17-U-S-FDA-Approves-VYALEV-TM-foscarbidopa-and-foslevodopa-for-Adults-Living-with-Advanced-Parkinsons-Disease

A phase 3 clinical trial called ECLIPSE has shown that 177Lu-PSMA-I&T significantly extends the median radiographic progression-free survival (rPFS) compared to hormone therapy in patients with PSMA-positive metastatic castration-resistant prostate cancer (mCRPC) previously treated with an ARPI (but

any study/trial done to show Provenge and Docetaxel can be done concurrently ? Tall_Allenany clinical trial to prove that Docetaxel cat be started along with Provenge. My dad’s PSA is increasing - doubling time is one month (4 weeks).

After 5 months on Acala twice a day and having just finished my Obin infusions, my lymphocyte count is now 3.6, down from 280 before my treatment began. Obin killed my leukemia cells so fast at the beginning I got hospitalized for 36 hours with TLS as my kidneys were overwhelmed with dead cancer cells

If your child has pediatric liver cancer, such as hepatoblastoma or hepatocellular carcinoma, please check out this webinar recording featuring Dr. Arun Rangaswami of UCSF Benioff Children's Hospitals and Dr. Allison O'Neill of Dana-Farber/Boston Children's Cancer Institute, discussing the path to diagnosis

We talked yesterday about bacteria to fight cancer, here is a new approach (of course preclinical still). We are talking about entering clinical trials within 10 years (I hope the exponential growth of knowledge will accelerate that) but it's really promising: This new method of culturing antitumor

Ok, it's from City of Hope, I am sure they are a great cancer institution, but I did not like the hype created around AOH1996 (where are the phase 1 results that had to be published before the end of September??)...but hopefully this research can give us some help, considering the fact that (at least

This development represents a significant advancement in cancer immunotherapy. By combining targeting, delivery, and immune activation into a single antibody, the approach addresses several challenges in current cancer treatments, such as specificity, efficacy, and safety. The ability to personalize